Merus N.V. Announces Proposed Public Offering of Common Shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street futures edge lower after AI selloff, telecom slide
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on concern over Middle East escalation
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Merus N.V. (MRUS) PT Raised to $85 at H.C. Wainwright
May 29, 2024 6:20 AM EDTH.C. Wainwright analyst Andrew Fein raised the price target on Merus N.V. (NASDAQ: MRUS) to $85.00 (from $65.00) while maintaining a Buy rating.
The analyst comments "Valuation and risks to reaching our price target. Given the recent ASCO update for petosemtamab, we are... More
Merus N.V. (MRUS) PT Raised to $80 at BofA Securities
May 29, 2024 5:13 AM EDTBofA Securities analyst Tazeen Ahmad raised the price target on Merus N.V. (NASDAQ: MRUS) to $80.00 (from $61.00) while maintaining a Buy rating.
The analyst comments "Merus reported 67% objective response rate (ORR; 1 CR, 15 PR) in 24 evaluable 1L head and neck squamous cell carcinoma (HNSCC)... More



